Latest filing published 18 May 2021 for Disc Medicine, Inc., €102k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -86.5%Entry US$317.40 · Close at T+365 US$42.90
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Jason Patrick Meyenburg: trading record in brief
Jason Patrick Meyenburg is a declared insider at 2 companies (chief executive); the most frequent names are Sucampo Pharmaceuticals, Inc. and Disc Medicine, Inc. In total, 3 filings cover trades dated from 6 September 2017 to 14 May 2021.
Every open-market trade on record is a purchase: 2 purchases worth €142k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2021 alone, the filings show 1 purchase and no sales.
The newest entry dates from 18 May 2021: an open-market purchase of €102k, in Disc Medicine, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Jason Patrick Meyenburg
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 13,000 shares@ US$9.4561100.0% of flowCommon StockSEC:0000899243-21-019762:0Canonical exit: 12 Aug 2021 (T+90)
- 30,228 shares@ US$18.0091.6% of flowCommon Stock, Class ASEC:0001171843-18-001100:0
- 4,000 shares@ US$12.138.4% of flowCommon Stock, Class ASEC:0001171843-17-005464:0Canonical exit: 5 Dec 2017 (T+90)
3 of 3 declarations
